Bio Rad Laboratories Stock

Bio Rad Laboratories EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Bio Rad Laboratories (BIO) as of Jul 31, 2026 is 25.59. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 25.74 — a change of -0.55% (lower).

EV/EBIT

25.59

YoY

-0.55%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Bio Rad Laboratories is 2026 25.59 . EV/EBIT (Enterprise Value to EBIT) of Bio Rad Laboratories was 2025 25.74 . It decreases by -0.55% lower compared to the previous year.

The Bio Rad Laboratories EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
48.69 base
Jan 1, 2020
39.68 base
Jan 1, 2021
45.05 base
Jan 1, 2022
25.96 base
Jan 1, 2023
27.54 base
Jan 1, 2024
34.19 base
Jan 1, 2025
30.26 base
Jan 1, 2026 (e)
-21.89 base
YEARPRICE-TO-EBIT
2026 est -21.89
2025 30.26
2024 34.19
2023 27.54
2022 25.96
2021 45.05
2020 39.68
2019 48.69
2018 -63.86
2017 61.96
2016 101.27
2015 24.51
2014 23.47
2013 21.15
2012 11.42
2011 9.29
2010 10.38
2009 11.72
2008 11.37
2007 21.05
2006 15.34
Access this data via the Eulerpool API
Get Free API Key

Bio Rad Laboratories Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Bio Rad Laboratories's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Bio Rad Laboratories's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Bio Rad Laboratories's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Bio Rad Laboratories grows earnings faster than its peers.

Bio Rad Laboratories Stock analysis

What does Bio Rad Laboratories do? Bio-Rad Laboratories Inc. is a leading company in the field of scientific research based in Hercules, California. The company was founded in 1952 by two brothers and has since developed into a multinational company with over 8,000 employees worldwide. Bio-Rad has branches in over 100 countries and its products are used in biotechnology, pharmaceuticals, and the food industry. History Bio-Rad was founded in 1952 by the couple David and Alice Schwartz. They started with the production of blood group serology tests and later expanded their product range to include immunchemicals, electrophoresis equipment, and antibodies. In the 1970s, Bio-Rad developed the first commercial protein A purification system, which is still an important component of protein research today. Business model Bio-Rad's business model is focused on providing high-quality products and services to support customers in their scientific research. The company has various divisions such as life science research, clinical diagnostics, and life science education, which offer products and solutions for scientists, researchers, and diagnosticians. Life science research The life science research division offers a wide range of products and services for biological research. This includes PCR systems, electrophoresis equipment, antibodies, proteins, cell counters, and much more. Bio-Rad's products are used by scientists and researchers around the world to better understand the intricacies of life and the mechanisms of diseases. Clinical diagnostics Bio-Rad's clinical diagnostics division provides a broad spectrum of diagnostic products and solutions for hospitals, laboratories, and medical facilities. The company provides clinical diagnostic instruments, reagents, testing systems, and software to support the diagnostic process. Life science education The life science education division offers innovative and interactive teaching and learning materials for scientific research to teachers, professors, and students. Bio-Rad's products and solutions support the better understanding of the intricacies of life and the mechanisms of diseases in the fields of biology, chemistry, and physics. Products Bio-Rad offers a wide range of products and solutions for research and diagnostics. These include, among others: PCR systems: Bio-Rad offers various PCR systems that help researchers and diagnosticians amplify and analyze DNA. The systems are highly precise and provide reliable results. Proteins and antibodies: Bio-Rad offers a wide selection of proteins and antibodies for research and diagnostics. The products include various types of proteins and antibodies needed for the analysis of protein functions and interactions. Electrophoresis equipment: Bio-Rad provides various electrophoresis equipment that plays an important role in research and diagnostics. The products include gel electrophoresis systems, Western blot systems, and devices for protein analysis. Clinical diagnostics: Bio-Rad offers a wide range of diagnostic products for hospitals, laboratories, and medical facilities. These include immunoassay products, blood group serology tests, and devices for the diagnosis of infectious diseases. In summary, Bio-Rad Laboratories Inc. is a leading company in the field of scientific research. The company offers a wide range of products and solutions for research and diagnostics, supporting scientists, researchers, and diagnosticians around the world in exploring the intricacies of life and better understanding diseases. Bio Rad Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Rad Laboratories stock

EV/EBIT (Enterprise Value to EBIT) of Bio Rad Laboratories is 25.59 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Bio Rad Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Bio Rad Laboratories